Table 3.
Distribution of fecal leukocytes in diarrheagenic E. coli infections among diarrhea and control samples
| Pathogen | Fecal leukocytes [no. of samples in indicated category/total no. of samples (%)] |
||||
|---|---|---|---|---|---|
| 0 L/hpf | 1–10 L/hpf | 11–20 L/hpf | 21–50 L/hpf | >50 L/hpf | |
| Diarrhea | |||||
| All diarrhea samples | 689/935 (73.7) | 136/935 (14.5) | 69/935 (7.4) | 31/935 (3.3) | 10/935 (1.1) |
| Diarrheagenic E. coli | |||||
| EAECa | 69/89 (77.5) | 15/89 (16.9) | 2/89 (2.2) | 2/89 (2.2) | 1/89 (1.1) |
| EPECa | 49/60 (81.7) | 6/60 (10.0) | 4/60 (6.7) | 1/60 (1.7) | |
| ETECa | 22/29 (75.9) | 3/29 (10.3) | 3/29 (10.3) | 1/29 (3.4) | |
| DAECa | 13/18 (72.2) | 2/18 (11.1) | 3/18 (16.6) | ||
| STECa | 1/4 (25.0) | 2/4 (50.0) | 1/4 (25.0) | ||
| Multiple DECb | 6/12 (50.0) | 6/12 (50.0) | |||
| Campylobacter sp.a | 61/99 (61.6) | 13/99 (13.1) | 13/99 (13.1) | 8/99 (8.1) | 4/99 (4.0) |
| Campylobacter sp. with DEC | 40/55 (72.7) | 7/55 (12.7) | 7/55 (12.7) | 1/55 (1.8) | |
| No pathogen identified | 376/508 (74.0) | 81/508 (15.9) | 29/508 (5.7) | 19/508 (3.7) | 3/508 (0.6) |
| Control | |||||
| All control samples | 484/539 (89.8) | 49/539 (9.1) | 5/539 (0.9) | 1/539 (0.2) | |
| Diarrheagenic E. coli | |||||
| EAECa | 62/68 (91.2) | 5/68 (7.4) | 1/68 (1.5) | ||
| EPECa | 54/61 (88.5) | 7/61 (11.5) | |||
| ETECa | 11/14 (78.6) | 2/14 (14.3) | 1/14 (7.1) | ||
| DAECa | 8/8 (100.0) | ||||
| STECa | 4/4 (100) | ||||
| Multiple DECb | 2/2 (100.0) | ||||
| Campylobacter sp.a | 49/53 (92.5) | 4/53 (7.5) | |||
| Campylobacter sp. with DEC | 24/25 (96.0) | 1/25 (4.0) | |||
| No pathogen identified | 270/304 (88.8) | 30/304 (9.9) | 4/304 (1.3) | ||
a
As the only pathogen isolated.
b
Only coinfection among DEC. Diarrhea samples (12 cases): DAEC plus EAEC; 1; EAEC plus STEC, 1; EAEC plus EPEC, 6; EAEC plus ETEC, 1; EPEC plus EIEC, 1; and EPEC plus ETEC, 2. Control (2 cases): EAEC plus EPEC, 1; EAEC plus ETEC plus DAEC, 1.